My research group studies cytokines and cytokine receptors and uses this research to develop selective designer proteins for the treatment of inflammatory and genetic diseases.
Dr. Dragon works on the development and optimization of innovative approaches using genetically modified T cells to provide novel treatment options for various diseases in the future.
Engineering antigen-specific Tregs to restore immune tolerance in liver autoimmunity and chronic inflammation — without broadly suppressing immune responses.
My lab bioengineers myeloid immune cells from pluripotent stem cells with enhanced potency. Protocols are optimized for cell therapy and high-throughput modelling of bone marrow diseases.
More
Prof. Dr. Florian Heidel
More
Clinical Department of Ear, Nose and Throat Medicine
Use of iPS cell technology to develop immune cells and macrophage-based therapies for regenerative medicine, infection treatment, and immunomodulation.
More
Dr. med. Theresa Maria Nägler
Bridging stem cell biology, immunology, and lung medicine to develop better models of disease and pave the way for future cell-based therapies.
